姓名：郑素军 性别：男 职称：主任医师、教授 招生院所：北京佑安医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：内科学（传染病）(博) 内科学（传染病）(硕) 研究方向名称：病毒性肝炎及相关肝衰竭，遗传代谢性肝病 电子信箱：zheng003@sina.com


社会任职
1. 胃肠病学与肝脏病学杂志编委
2. 《中华临床医师杂志（电子版）》审稿专家
3. 北京医药科学技术发展协会生物医药专家
4. 国家自然基金评审专家
5. 《临床肝胆病杂志》审稿专家
6. 中华医学会北京分会肝病医学人工肝与肝衰竭学组委员
7. “健康中国-肝胆病防治行动”全国肝胆病咨询专家
8. 中华医学会肝病学分会遗传代谢性肝病协作组委员、秘书长
9. 北京医学会肝病学分会青年委员会
10. 中国研究型医院学会肝病专委会肝纤维化学组委员
11. World Journal of Hepatology杂志编委
12. World Journal of Gastroenterology审稿专家
13. 实用肝脏病杂志编委
个人简历
1. 199109-199607:河南医科大学 本科生
2. 199607-199909:河南省濮阳市安阳地区医院 住院医师
3. 199909-200207:四川省泸州医学院 硕士研究生
4. 200209-200507:重庆医科大学 博士研究生
5. 200507-200710:首都医科大学附属北京佑安医院人工肝中心 主治医师
6. 200710-201210:首都医科大学附属北京佑安医院人工肝中心 副主任医师
7. 201210-:首都医科大学附属北京佑安医院人工肝中心 主任医师
8. 201405-:首都医科大学附属北京佑安医院人工肝中心 行政副主任
重要学术论文
1. Xiangjun Qian, Sujun Zheng#, Leijie Wang, Mingjie Yao, Guiwen Guan 1 , Xiajie Wen 1 , Ling Zhang 3 , Qiang Xu 1 , Xiangmei Chen 1 , Jingmin Zhao 4 , Zhongping Duan 2 , Fengmin Lu 1.Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection With Different Stages of Liver Injuries. Dis Markers. 2019,eCollection 2019:【未填写起止页码】.SCI
2. Jie Bai,Lei Luo,Shuang Liu,Chen Liang,Li Bai, Yu Chen , Sujun Zheng*, Zhongping Duan*.Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia. Front Genet. 2019, eCollection 2019:【未填写起止页码】.SCI
3. Bai L, Fu L, Li L, Ren F, Zheng Q, Liu S, Han Y, Zheng S*, Chen Y, Duan Z..Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages. Med Sci Monit. 2018, 24:2675-2682.SCI
4. Zheng Q, Bai L, Zheng S#,Liu M, Zhang J, Wang T, Xu Z, Chen Y, Li J, Duan Z*..Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system.. Mol Med Rep. 2017,16(5):7199-7204.SCI
5. Li JF, Zheng SJ#, Wang LL, Liu S, Ren F, Chen Y, Bai L, Liu M, Duan ZP..Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl‑2/Bax pathway. Mol Med Rep. 2017,16（5）:7355-7360.SCI
6. Bian DD, Zhou HY, Liu S, Liu M, Duan C, Zhang JY, Jiang YY, Wang T, Chen Y, Wang Z, Zheng SJ*, Duan ZP. .Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals. Medicine (Baltimore). 2017,96（34）:e7885.SCI
7. Cheng XP, Zhao J, Chen Y, Meng FK, Xu B, Yu HW, Meng QH, Liu YM, Zhang SB, Meng S, Zhang JY, Zhang JY, Duan ZP, Zheng SJ*.Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis . Eur J Gastroenterol Hepatol. 2016,28(4):444-448.SCI
8. Zheng QF, Zhang JY, Wu JS, Zhang Y, Liu M, Bai L, Zhang JY, Zhao J, Chen Y, Duan ZP, Zheng SJ*.Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study. Medicine (Baltimore). 2016,95(6):e2639.SCI
9. Zhang JY#, Qu F#, Li JF, Liu M, Ren F, Zhang JY, Bian DD, Chen Y, Duan ZP, Zhang JL, Zheng SJ*.Up-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort Study.Medicine (Baltimore). 2016 Jun;95(23). Medicine (Baltimore). 2016,95(23):e3773.SCI
10. Li JF, Qu F, Zheng SJ#, Ren F, Wu HL, Liu M, Ren JY, Chen Y, Duan ZP, Zhang JL.Plasma sphingolipids: Potential biomarkers for severe hepatic fibrosis in chronic hepatitis C. Mol Med Rep. 2015,12(1):323-330.SCI
11. Zheng SJ, Qu F, Li JF, Zhao J, Zhang JY, Liu M, Ren F, Chen Y, Zhang JL, Duan ZP. Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection. Int J Infect Dis. 2015,33:149-155.SCI
12. Ren Y, Liu M, Zhao J, Ren F, Chen Y, Li JF, Zhang JY, Qu F, Zhang JL, Duan ZP, Zheng SJ*.Serum vitamin D3 does not correlate with liver fibrosis in chronic hepatitis C. World J Gastroenterol. 2015,21(39）:11152-11159.SCI
13. 2.Liu M, Zheng SJ#,Xu W, Zhang J, Chen Y, Duan Z..Changing Interdigestive Migrating Motor Complex in Rats under Acute Liver Injury. Biomed Res Int. 2014,2014:634281.SCI
14. Qu F#, Zheng SJ#(co-first author), Wu CS, Jia ZX, Zhang JL*, Duan ZP*.. Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure. PLoS One. 2014,9(8):e104988.SCI
15. J.-F. Li#，F. Qu#，S.-J. Zheng#，H.-L. Wu，M. Liu，S. L，Y. Ren，F. Ren，Y. Chen，Z.-P. Duan*，J.-L. Zhang*. Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection. Eur J Clin Microbiol Infect Dis . 2014,33(10) :1725-1732 .SCI
16. Li JF, Liu S, Ren F, Liu M, Wu HL, Chen Y, Zou HB, Bai L, Li Y, Zheng SJ*, Duan ZP..Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study. . Int J Infect Dis. 2014,27:49-53.SCI
17. Li JF, Qu F, Zheng SJ#, Ren JY, Wu HL, Liu M, Liu H, Ren F, Chen Y, Zhang JL, Duan ZP..Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level.. PLoS One. 2014,9(4):e95095.SCI
18. Zheng SJ, Liu S, Liu M, McCrae MA, Li JF, Han YP, Xu CH, Ren F, Chen Y, Duan ZP..Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol. 2014,20(9):2403-2411.SCI
19. Qu F, Zheng SJ#, Wu CS, Jia ZX, Zhang JL, Duan ZP..Lipidomic profiling of plasma in patients with chronic hepatitis C infection.. Anal Bioanal Chem. 2014,406(2):555-564.SCI
20. Zhao BB, Zheng SJ#,Gong LL, Wang Y, Chen CF, Jin WJ, Zhang D, Yuan XH, Guo J, Duan ZP, He YW.T lymphocytes from chronic HCV-infected patients are primed for activation-induced apoptosis and express unique pro-apoptotic gene signature. . PLoS One. 2013,8(10):e77008.SCI
21. 任艳,郑素军*,段钟平.丙型肝炎慢性化的免疫机制研究进展. 中华肝脏病杂志. 2013,21(2):151-153.核心期刊
22. Liu Mei ，Zheng Sujun（co-first author),Xiao Shengbin,Shen Enyun,Yu Hao,Chen Peng,Chen Yu,Liu Xuhua,Zhang Jing,Duan Zhongping .Predictive value of serum gelsolin in hepatitis B virus (HBV)-related chronic liver disease . African Journal of Biotechnology. 2012,11(20):4640-4645.SCI
23. 张 莹, 孔贺利, 郑素军, 刘 梅, 陈 煜, 刘 霜, 段钟平.SMAD3为靶的shRNA重组慢病毒对大鼠肝的再生作用. 世界华人消化杂志 . 2012,20(35):3431-3438.核心期刊
24. 郑素军,邢欣悦,韩源平,武聚山,王世美,张 莹,刘 梅,陈 煜,刘 霜,段钟平.TGF-β1对大鼠HSC-T6 细胞增殖、细胞周期和胶原分泌的影响. 实用肝脏病杂志. 2012,15(4):327-331.核心期刊
25. 王世美，郑素军*，段钟平..肝病中TGF-β与microRNAs相互作用的研究.. 胃肠病学与肝病学杂志. 2011,20（2）:99-102.核心期刊
26. 邢欣悦, 刘 梅, 郑素军*, 张 莹, 武聚山, 俞 豪, 李长勇, 白 丽, 刘 霜, 段钟平.血清载脂蛋白水平在HBV慢性肝病肝损伤程度判断中的作用. 世界华人消化杂志. 2011,19（3）:295-300.核心期刊
27. 张莹, 郑素军*,段钟平. microRNA-21在肝脏中的作用. 世界华人消化杂志 . 2010,18(25):2621-2625.核心期刊
28. 邢欣悦，陈鹏 ，郑素军*,段钟平..SMAD3蛋白在肝纤维化中的作用研究进展. 肝脏. 2010,15(2):130-133.核心期刊
29. 郑素军，张晶，孟砂，陶明铃，王嵬，庞星火，孙美平，苏月，段钟平..借助实际病例对北京市中心城区医院乙型肝炎诊治能力的调查. 中国全科医师杂志. 2010,13（9C）:3058-3061，3064.核心期刊
30. Li, C., Zheng, S., You, H., Liu, X., Lin, M., Yang, L., Li, L..Sphingosine 1-Phosphate(S1P)/S1P Receptors Is Involved in Human Liver Fibrosis by Action on Hepatic Myofibroblasts Motility. Journal of Hepatology . 2010,doi: 10.1016/j.jhep.2010.08.028:doi: 10.1016/j.jhep.2010.08.028.SCI
31. 郑素军,段钟平,郑晓玲,张凤霞，赵军，林汝仙，任红 .血管内皮生长因子受体2反义核酸体内抑制人乳腺癌生长作用研究. 山东医药. 2009,49（4）:36-38.核心期刊
32. 郑素军,陈鹏,段钟平.siRNA在实验性急性肝衰竭中的治疗作用研究进展. 中华肝脏病杂志. 2009,17（3）:238-240.核心期刊
33. 段钟平，郑素军，陈 鹏.肝衰竭预后评价新标志物研究进展. 传染病信息. 2009,22(5):265-268.核心期刊
34. 郑素军， 郑晓玲， 林汝仙， 张凤霞，任红，钟森， 王升启. 血管内皮生长因子受体2反义寡核苷酸对人乳癌细胞生长的影响. 郑州大学学报：医学版. 2006,41(2):248-250.核心期刊
35. 郑素军, 林汝仙，夏云， 伯晓晨， 任红，钟森，王升启.血管内皮生长因子受体2为靶的反义寡核苷酸筛选及其对乳腺癌MCF-7细胞的抗肿瘤作用.. 中华肿瘤杂志. 2006,28(4):248-252.核心期刊
36. Zheng sujun，Lin ruxian, Xia yun, .Selection and their antitumor activity of antisense oligonucleotides targeting messenger RNA of vascular endothelial growth factor receptor 2. Chinese Journal of Cancer Research. 2005,17(3）:161-170.核心期刊
37. 郑素军, 林汝仙，夏云 ，黄爱龙，钟森，王升启， 任红.KDR为靶的反义寡核苷酸、siRNA活性比较. 重庆医科大学学报. 2005,30(3):340-344.核心期刊
38. 郑素军，夏云，任红，钟森， 杨英， 陶鹏，王升启.端粒酶逆转录酶小干扰RNA对肝癌细胞的体外抑制作用. 中华肝脏病杂志. 2004,12(9):530-533.核心期刊
39. Zheng SJ, Zhong S,Zhang JJ, Chen F, Ren H, Deng CL..Distribution and anti-HBV effects of antisense oligodeoxynuleotides conjugated to galactosylated poly-L-lysine. World Journal of Gastroenterology. 2003,9(6):1251-1255.SCI
主编或副主编的著作/译著
重要奖项
1. 2012年首都十大疾病科技攻关（2010-2012）创新型科技成果奖。 “重型肝炎肝衰竭临床诊疗关键技术及相关机制研究” 201212